About Elevate Labs
Elevate Labs develops mobile applications aimed at improving cognitive skills and mental well-being. Their primary app, Elevate, helps users enhance their reading, writing, and math abilities, and has received recognition as Apple's App of the Year. Another app, Balance, provides personalized meditation sessions designed to reduce stress, improve sleep, and enhance focus, which earned it the title of Google's Best App of 2021. Unlike many competitors, Elevate Labs operates as a fully distributed company, emphasizing a healthy work culture and employee satisfaction. The company's goal is to support individuals in their journey towards better cognitive and mental health through subscription-based services and in-app purchases.
San Francisco, CaliforniaHeadquarters
2014Year Founded
$20.7MTotal Funding
SERIES_BCompany Stage
Consumer Software, Education, HealthcareIndustries
51-200Employees
Benefits
Competitive salary and equity
Medical, dental, and vision insurance for you and your family
Distributed team flexibility, with a home-office stipend and co-working reimbursement
Annual learning, wellness, and travel stipends
Generous PTO, flexible sick leave, and paid parental leave
Risks
Competition from cheaper mental wellness apps could erode Elevate Labs' market share.
Changes in App Store policies may impact Elevate Labs' revenue streams.
Consumer concerns about data privacy could decrease user trust in Elevate Labs.
Differentiation
Elevate Labs offers award-winning apps like Elevate and Balance for cognitive improvement.
The company personalizes meditation with Balance, enhancing stress reduction and focus.
Elevate Labs fosters a robust company culture, enhancing employee experience and innovation.
Upsides
Increased interest in digital mental health boosts Elevate Labs' user base potential.
Rise of personalized learning aligns with Elevate Labs' cognitive training mission.
Remote work trend increases demand for Elevate Labs' mental health tools.
Funding
Total raised$20.72 M
Latest valuation$35.50 M
StageSERIES_B
SERIES B
8/31/2019$7
$35.50 MSERIES A
7/31/2014$6
$32.50 M